ICB International Revenue and Competitors
Estimated Revenue & Valuation
- ICB International's estimated annual revenue is currently $2.5M per year.
- ICB International's estimated revenue per employee is $155,000
Employee Data
- ICB International has 16 Employees.
- ICB International grew their employee count by 7% last year.
ICB International's People
Name | Title | Email/Phone |
---|---|---|
1 | President and CEO | Reveal Email/Phone |
2 | Founding Chief Operations Officer, Innovative California Biosciences, Inc. | Reveal Email/Phone |
3 | Senior Research Associate | Reveal Email/Phone |
ICB International Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is ICB International?
Innovative California Biosciences International, Inc.,('ICBI'), an immunology and biomedicine company, has developed a proprietary blood-brain barrier (BBB) permeable technology to address issues relating to the diseases of the central nervous system (CNS). This platform technology is now being leveraged to develop FDA (Food and Drug Administration) approved non-invasive diagnostics and therapeutics for neurodegenerative, cancer, and infectious diseases.
keywords:N/AN/A
Total Funding
16
Number of Employees
$2.5M
Revenue (est)
7%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | N/A | 16 | -16% | N/A |
#2 | $2.6M | 16 | -47% | N/A |
#3 | $1.4M | 16 | 0% | N/A |
#4 | $1.5M | 17 | -23% | N/A |
#5 | $1.6M | 18 | 13% | N/A |